A Phase 1 Trial of MSP2-C1, a Blood-Stage Malaria Vaccine Containing 2 Isoforms of MSP2 Formulated with Montanide® ISA 720
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Phase 1 Trial of MSP2-C1, a Blood-Stage Malaria Vaccine Containing 2 Isoforms of MSP2 Formulated with Montanide® ISA 720
Authors
Keywords
-
Journal
PLoS One
Volume 6, Issue 9, Pages e24413
Publisher
Public Library of Science (PLoS)
Online
2011-09-20
DOI
10.1371/journal.pone.0024413
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasmodium falciparum msp1, msp2 and glurp allele frequency and diversity in sub-Saharan Africa
- (2011) Felista Mwingira et al. MALARIA JOURNAL
- Recombinant protein vaccines against the asexual blood-stages ofPlasmodium falciparum
- (2010) Robin F. Anders et al. Human vaccines & immunotherapeutics
- Phase 1 safety and immunogenicity trial of the Plasmodium falciparum blood-stage malaria vaccine AMA1-C1/ISA 720 in Australian adults
- (2010) Mark A. Pierce et al. VACCINE
- The Relationship between Anti-merozoite Antibodies and Incidence of Plasmodium falciparum Malaria: A Systematic Review and Meta-analysis
- (2010) Freya J. I. Fowkes et al. PLOS MEDICINE
- In Vitro Growth-Inhibitory Activity and Malaria Risk in a Cohort Study in Mali
- (2009) P. D. Crompton et al. INFECTION AND IMMUNITY
- Immunoglobulin G Subclass-Specific Responses against Plasmodium falciparum Merozoite Antigens Are Associated with Control of Parasitemia and Protection from Symptomatic Illness
- (2009) D. I. Stanisic et al. INFECTION AND IMMUNITY
- Plasmodium falciparum merozoite surface protein 2 is unstructured and forms amyloid-like fibrils
- (2009) Christopher G. Adda et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- Artemisinin Resistance inPlasmodium falciparumMalaria
- (2009) Arjen M. Dondorp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvants for malaria vaccines
- (2009) R. N. COLER et al. PARASITE IMMUNOLOGY
- Allele-specific antibodies toPlasmodium falciparummerozoite surface protein-2 and protection against clinical malaria
- (2009) F. H. A. OSIER et al. PARASITE IMMUNOLOGY
- The Quantity and Quality of African Children's IgG Responses to Merozoite Surface Antigens Reflect Protection against Plasmodium falciparum Malaria
- (2009) David Courtin et al. PLoS One
- Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates
- (2009) Christian Flueck et al. VACCINE
- Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies
- (2008) Kristina E.M. Persson et al. JOURNAL OF CLINICAL INVESTIGATION
- Immunization With Analog Peptide in Combination With CpG and Montanide Expands Tumor Antigen-specific CD8+ T Cells in Melanoma Patients
- (2008) Julien Fourcade et al. JOURNAL OF IMMUNOTHERAPY
- Safety and Immunogenicity of a Malaria Vaccine, Plasmodium falciparum AMA-1/MSP-1 Chimeric Protein Formulated in Montanide ISA 720 in Healthy Adults
- (2008) Jinhong Hu et al. PLoS One
- Safety and Immunogenicity of a Recombinant Plasmodium falciparum AMA1 Malaria Vaccine Adjuvanted with Alhydrogel™, Montanide ISA 720 or AS02
- (2008) Meta Roestenberg et al. PLoS One
- Acquisition of Growth-Inhibitory Antibodies against Blood-Stage Plasmodium falciparum
- (2008) Fiona J. McCallum et al. PLoS One
- A Phase 1 trial of PfCP2.9: An AMA1/MSP1 chimeric recombinant protein vaccine for Plasmodium falciparum malaria
- (2008) Elissa Malkin et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search